Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073554
Status:
COMPLETED
Last Update Posted:
2009-12-17
First Post:
2003-11-24
Brief Title:
Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion
Sponsor:
ARCA Biopharma Inc
Organization:
ARCA Biopharma Inc
Study Overview
Official Title:
A Phase 2 Multicenter Open-Label Dose-Escalation Study to Evaluate the Safety and Activity of Alfimeprase in Patients With Acute Peripheral Arterial Occlusion
Status:
COMPLETED
Status Verified Date:
2006-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is for patients with acute occlusion of one of the arteries supplying blood to the leg The trial is designed to determine the safety and activity of a novel clot dissolving thrombolytic drug alfimeprase
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NAPA-1 | None | None | None |